Thyroid dysfunction in patients with end-stage renal failure on hemodialysis: the role of the autoimmune component
https://doi.org/10.36485/1561-6274-2025-29-4-53-58
EDN: PGSYQW
Abstract
BACKGROUND. Thyroid dysfunction is a common complication in patients with end-stage renal disease (ESRD) receiving maintenance hemodialysis. However, the role of the autoimmune component in these disorders remains insufficiently studied.
THE AIM: to study the features of thyroid dysfunction and the role of the autoimmune component in its development in patients with ESRD on maintenance hemodialysis.
PATIENTS AND METHODS. The study included 134 patients with ESRD on maintenance hemodialysis. All participants underwent comprehensive clinical and laboratory evaluation, including measurement of thyroid-stimulating hormone (TSH), free T3 and T4, anti-thyroid peroxidase antibodies (anti-TPO), as well as basic biochemical and hematological parameters. Statistical analysis was performed using standard comparative methods.
RESULTS. Hypothyroidism was diagnosed in 30.6 % of patients; however, elevated anti-TPO levels were found only in a quarter of them. In patients with hypothyroidism, the median anti-TPO level was significantly higher than in the euthyroid group (1.50 [0.70; 7.50] vs. 0.80 [0.30; 3.70] IU/mL, p = 0.021). Sex, age, body mass index, and renal disease etiology did not influence the development of hypothyroidism or elevated anti-TPO.
CONCLUSION. Among patients with ESRD on hemodialysis, hypothyroidism is common, while the autoimmune mechanism is present only in a subset of cases. Thyroid dysfunction is multifactorial and should be taken into account in diagnosis and management.
About the Authors
A. R. VolkovaRussian Federation
Prof. Anna R. Volkova, MD, PhD, DMedSci
197022, St. Petersburg, 6–8 L. Tolstoy st., bldg. 10
Phone: +7 (812) 338-66-46
Yu. Sh. Khalimov
Russian Federation
Prof. Yuriy Sh. Khalimov, MD, PhD, DMedSci
197022, St. Petersburg, 6–8 L. Tolstoy st., bldg. 10
Phone: +7 (812) 338-66-46
O. D. Dygun
Russian Federation
Olga D. Dygun, MD, PhD
197022, St. Petersburg, 6–8 L. Tolstoy st., bldg. 10
Phone: +7 (812) 338-66-46
M. S. Chentsov
Russian Federation
Mikhail S. Chentsov, MD
197022, St. Petersburg, 6–8 L. Tolstoy st., bldg. 10
Phone: (812) 338-66-46
A. M. Esayan
Russian Federation
Prof. Ashot M. Esayan, MD, PhD, DMedSci
197022, St. Petersburg, 17 L. Tolstoy st., bldg. 54
Phone: +7 (812) 234-91-91
B. G. Lukichev
Russian Federation
Prof. Boris G. Lukichev, MD, PhD, DMedSci
197022, Russia, St. Petersburg, 17 L. Tolstoy st., bldg. 54
Phone: +7 (812) 338-69-01с
A. V. Karunnaya
Russian Federation
Anna V. Karunnaya, MD
197022, Russia, St. Petersburg, 17 L. Tolstoy st., bldg. 54
Phone: +7 (812) 338-69-01
References
1. Khan JA, Kanwal S, Aamir MS, Ali A, Ahmad J, Mumtaz A et al. Thyroid dysfunction in patients with chronic kidney disease. Prof Med J 2024;31(09):1288–1293. doi: 10.29309/TPMJ/2024.31.09.8223
2. Griffin TP, Griffin MD. Thyroid Dysfunction and Chronic Kidney Disease: Unravelling the Connection. Mayo Clin Proc 2024;99(1):7–9. doi: 10.1016/j.mayocp.2023.11.012
3. Hafed AB, Abdulkareem RK, Almalki AM, Alradadi JI, Aldosari A, Khan ZH. Assessment of Thyroid Function in Chronic Kidney Disease Patients at King Abdulaziz Medical City. Cureus 2024. doi: 10.7759/cureus.73180
4. Upadhyay DA, Gupta DA, Mathur DM, Chaurasia DA, Kumar DA. Prevalence of subclinical and overt hypothyroidism in diabetic and non-diabetic chronic kidney disease (CKD) and effect of treatment on glomerular filtration rate (GFR). Int J Life Sci Biotechnol Pharma Res 2024;13(6):450–455. doi: 10.69605/ijlbpr_13.6.2024.86
5. Agahi S, Amouzegar A, Honarvar M, Azizi F, Mehran L. Interrelationship between thyroid hormones and reduced renal function, a review article. Thyroid Res 2024;17(1):14. doi: 10.1186/s13044-024-00201-y
6. Sibanda LA, Olivier SM, Yacoubou ID, Kaka AK, Salissou MTM. Prevalence of Thyroid Dysfunction among Patients with Chronic Kidney Disease Attending Diagnostic Laboratory Services, Bulawayo, Zimbabwe. Divers Dis Prev Res Integr 2024:22–30. doi: 10.24252/diversity.v5i1.49669
7. Karanikas G, Schuetz M, Wahl K, Paul M, Kontur S, Pietschmann P et al. Relation of anti-TPO autoantibody titre and Tlymphocyte cytokine production patterns in Hashimoto’s thyroiditis. Clin Endocrinol (Oxf) 2005;63(2):191–196. doi: 10.1111/j. 1365-2265.2005.02324.x
8. Khan SR, Peeters RP, van Hagen PM, Dalm V, Chaker L. Determinants and Clinical Implications of Thyroid Peroxidase Antibodies in Middle-Aged and Elderly Individuals: The Rotterdam Study. Thyroid 2021. doi: 10.1089/thy.2021.0403
9. Jantikar MA. A study on relationship between thyroid peroxidase antibodies (Anti-TPO antibodies) and thyroid dysfunction patients. Int J Clin Biochem Res 2020;7(2):238–242. doi: 10.18231/j.ijcbr.2020.051
10. Mishra C, Sarkari M, Mishra S. To study the prevalence of thyroid autoimmune antibody in chronic kidney disease patients with hypothyroidism in Eastern Uttar Pradesh. Panacea J Med Sci 2022;12(3):634–640. doi: 10.18231/j.pjms.2022.118
11. Volkova AR, Dygun OD, Abramova IM, Nechaeva EV, Galkina OV, Belyakova LA. Thyroid dysfunction in patients with chronic kidney disease. Nephrology (Saint-Petersburg) 2019;23(1):60–66. (In Russ.) https://doi.org/10.24884/1561-6274-2019-23-1-60-66
12. Selvathesan N, Jefferies C, Albert B, Yonge G, Dickens A. Severe iodine-induced hypothyroidism in an infant on peritoneal dialysis: A salient reminder of the Wolff-Chaikoff effect of iodine. J Paediatr Child Health 2023;59(2):381–384. doi: 10.1111/jpc.16276
13. Iglesias P, Bajo MA, Selgas R, Díez JJ. Thyroid dysfunction and kidney disease: An update. Rev Endocr Metab Disord 2017;18(1):131–144. doi: 10.1007/s11154-016-9395-7
Review
For citations:
Volkova A.R., Khalimov Yu.Sh., Dygun O.D., Chentsov M.S., Esayan A.M., Lukichev B.G., Karunnaya A.V. Thyroid dysfunction in patients with end-stage renal failure on hemodialysis: the role of the autoimmune component. Nephrology (Saint-Petersburg). 2025;29(4):53-58. (In Russ.) https://doi.org/10.36485/1561-6274-2025-29-4-53-58. EDN: PGSYQW
JATS XML


































